Cite
HARVARD Citation
Kelm, S. et al. (2013). C‐4 Modified Sialosides Enhance Binding to Siglec‐2 (CD22): Towards Potent Siglec Inhibitors for Immunoglycotherapy1. Angewandte Chemie international edition. 52 (13), pp. 3616-3620. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kelm, S. et al. (2013). C‐4 Modified Sialosides Enhance Binding to Siglec‐2 (CD22): Towards Potent Siglec Inhibitors for Immunoglycotherapy1. Angewandte Chemie international edition. 52 (13), pp. 3616-3620. [Online].